the aid library

Filter

4705

Achieving Health Equity in Contested Areas of Southeast Myanmar

Davis, Bill; Jolliffe, Kim The Asia Foundation (2016) C1

In many of Myanmar’s contested regions, healthcare services are provided through two parallel governance systems – by the government’s Ministry of Health, and by providers linked to ethnic armed organizations. Building upon efforts to build trust between these two actors following ceasefires s ... more

App for its Medical Eligibility Criteria for Contraceptive Use

Johns Hopkins Bloomberg School of Public HealthCenter for Communication Programs and World Health Organization (2022) C_WHO

Recommendations on the initiation and continuing use of nine common types of contraceptive methods are covered by the tool. In addition to looking at individual medical conditions or characteristics, users may also easily combine multiple conditions or characteristics and view the guidance on each c ... more

Guidelines for submission of a health research proposal Version 3 DRAFT

Ministry of Health, Kingdom of Lesotho (2013) C2

Introduction, preparations to submit, submission procedure, requirements, main narrative of the protocol, definition of terms. | For Research and ethics clearance in Lesotho

Adolescent HIV Care and Treatment: A Training Curriculum for Health Workers . Module 2 Participant

ICAP; CDC; University Teaching Hospital, et al. (2011)

The Georgian national HIV/AIDS strategic plan for 2016–2018

CCM Georgia (2019) C2

Endorsed by the CCM Georgia on April 15th 2015 Accessed: 26.09.2019

Nepal: Leprosy Guideline 2070 (Nepali Version)
recommended

Government of Nepal Ministry of Health Department of Health Services Leprosy Control Division (2013) C1

Five-Year Strategic Plan for Young People's Health (2016-2020)

The Republic of the Union of Myanmar, Ministry of Health and Sports (2017) C1

The National Strategic Plan is based on the following guiding principles:
1) Life-course approach: adolescence is a key decade in the course of life that inﬂuences the health outcomes later in life.
2) Comprehensive approach: It recognizes the cross cutting health and development needs o ... more

Definição e categorização do momento da transmissão vertical do SARS-CoV-2 Informe científico 8 de fevereiro de 2021

Organização Mundial da Saúde (OMS) OPAS, OMS (2021) C_WHO

Definition and categorization of the time of vertical transmission of SARS-CoV-2 Scientific report 8 February 2021

Universal Periodic Review of Albania - 33rd Session

Albania Center for Population and Development (ACPD); Albanian Association of People Living with HIVAIS; Roma Active Albania; STOP AIDS; Aksion Plus; et al. (2019) C2

Joint Stakeholder Submission Accessed: 29.09.2019

Guidelines for COVID-19 testing and quarantine of air travellers - Addendum to the Aviation Health Safety Protocol

European Centre for Disease Prevention and Control ECDC (2020) CC

This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic, noting th ... more

Saving Mothers, Giving Life. Maternal Mortality Endline Census in Selected Districts

Central Statistical Office (CSO) Zambia, Ministry of Health (MOH) Zambia, and ICF, et al. (2017) C1

The path that ends AIDS: UNAIDS Global AIDS Update 2023
recommended

UN Children's Fund UNICEF (2023) CC

This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not ... more

Global vaccine safety blueprint 2.0 (GVSB2.0) 2021-2023

World Health Organization WHO (2022) C_WHO

Independent Monitoring Board of the Global Polio Eradication Initiative (Fifteenth Report: December 2017)

Global Polio Eradication Initiative (2017) C1

The report reviews progress with the task of planning and implementing measures necessary to secure a completely polio-free world. It also examines actions aimed at ensuring successful transfer of polio assets, innovations developed and lessons learned to countries’ public health programmes and ot ... more

The Wise List 2015

Stockholm Drug and Therapeutics Committee (2015) C_WHO

with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden

Adolescent Girls in Disaster & Conflict: Interventions for Improving Access to Sexual and Reproductive Health Services

S. Guthridge-Gould UNFPA (United Nations Population Fund) (2016) C2

Basic Epidemiology

Bonita, R.; R.Beaglehole, and T. Kjellström World Health Organization WHO (2006) C_WHO

2nd edition

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for ... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Communicable disease surveillance and response systems

World Health Organization WHO (2006) C_WHO

Guide to monitoring and evaluating